Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus
- PMID: 7945503
- DOI: 10.1002/art.1780370917
Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus
Abstract
Objective: We have previously described associations between an allele of the interleukin-1 receptor antagonist gene (IL1RN) and several inflammatory diseases. In this study we tested the IL1RN gene as a possible marker in patients with systemic lupus erythematosus (SLE).
Methods: Eighty-one SLE patients and 261 ethnically matched control subjects were genotyped by polymerase chain reaction.
Results: We found an increase in both frequency and carriage rate of IL1RN*2 in the SLE group. This association strengthened with extensive disease and particularly with the presence of photosensitivity and discoid skin lesions.
Conclusion: We describe a novel association between IL1RN*2 and SLE. Carriage of the allele seems to influence severity rather than susceptibility to SLE. We postulate that the association of this polymorphism with disease severity is a widespread feature of common inflammatory and autoimmune diseases.
Similar articles
-
Interleukin-1 receptor antagonist gene polymorphism in chinese patients with systemic lupus erythematosus.Clin Rheumatol. 2002 Jun;21(3):255-7. doi: 10.1007/s10067-002-8292-5. Clin Rheumatol. 2002. PMID: 12111633
-
Lack of association between an interleukin-1 receptor antagonist gene polymorphism and systemic lupus erythematosus.Dis Markers. 1995 Mar;12(2):135-9. doi: 10.1155/1994/464787. Dis Markers. 1995. PMID: 7614783
-
A candidate gene analysis of three related photosensitivity disorders: cutaneous lupus erythematosus, polymorphic light eruption and actinic prurigo.Br J Dermatol. 2001 Aug;145(2):229-36. doi: 10.1046/j.1365-2133.2001.04339.x. Br J Dermatol. 2001. PMID: 11531784
-
Association of angiotensin-converting enzyme insertion/deletion polymorphism with susceptibility to systemic lupus erythematosus: a meta-analysis.Int J Rheum Dis. 2018 Feb;21(2):447-457. doi: 10.1111/1756-185X.13236. Epub 2017 Dec 5. Int J Rheum Dis. 2018. PMID: 29205894 Review.
-
Molecular genetics of cutaneous lupus erythematosus.Clin Exp Dermatol. 2001 Mar;26(2):184-91. doi: 10.1046/j.1365-2230.2001.00793.x. Clin Exp Dermatol. 2001. PMID: 11298113 Review.
Cited by
-
Polymorphism of Interleukin 1B May Modulate the Risk of Ischemic Stroke in Polish Patients.Medicina (Kaunas). 2019 Sep 2;55(9):558. doi: 10.3390/medicina55090558. Medicina (Kaunas). 2019. PMID: 31480765 Free PMC article.
-
Interleukin-1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis.Clin Exp Immunol. 2002 Feb;127(2):331-6. doi: 10.1046/j.1365-2249.2002.01743.x. Clin Exp Immunol. 2002. PMID: 11876758 Free PMC article.
-
Meta-analysis of associations of IL1 receptor antagonist and estrogen receptor gene polymorphisms with systemic lupus erythematosus susceptibility.PLoS One. 2014 Oct 6;9(10):e109712. doi: 10.1371/journal.pone.0109712. eCollection 2014. PLoS One. 2014. PMID: 25286391 Free PMC article.
-
Association of Interleukin-1 Receptor Antagonist ( IL-1RA ) Gene Polymorphism with Community-Acquired Pneumonia in North Indian Children: A Case-Control Study.Glob Med Genet. 2023 Jun 16;10(2):109-116. doi: 10.1055/s-0043-1770056. eCollection 2023 Jun. Glob Med Genet. 2023. PMID: 37332685 Free PMC article.
-
A link between osteomyelitis and IL1RN and IL1B polymorphisms-a study in patients from Northeast Brazil.Acta Orthop. 2017 Oct;88(5):556-561. doi: 10.1080/17453674.2017.1348439. Epub 2017 Jul 6. Acta Orthop. 2017. PMID: 28682145 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical